CFDA / SAMR is absolutely critical for the valuation of IF companies. The performance of SP between A2 & BAL tells the story. I reckon the final approval alone could send the market cap at least double from current level, then any growth of sales post approval will keep pushing the SP beyond $3 etc.
I’m very interested about the progress of the organic milk powder. It could be a real kicker if the execution is smart. I think the management team has a great vision of replicating another A2 or even better one over here. To me this stock might worth long term holding.
I wrote to the company about the progress of organic milk powder as well as other plans of increasing brand awareness on both of Australian & international soil. I understand they can’t tell me anything that the market doesn’t know about. Hopefully I can hear some big picture thinking.
Chart is strong & pointing to another leg up soon which could well timed with the SAMR Ann, or other positive news from the Co. I have started buying small parcels & will keep doing on any weakness. Good luck to all![]()
- Forums
- ASX - By Stock
- WNX
- WHA uptrend sign begins
WHA uptrend sign begins, page-12
-
- There are more pages in this discussion • 89 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WNX (ASX) to my watchlist
|
|||||
Last
3.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.98M |
Open | High | Low | Value | Volume |
3.0¢ | 3.1¢ | 3.0¢ | $48.02K | 1.587M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 10659 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.1¢ | 257351 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 10659 | 0.030 |
4 | 1223886 | 0.028 |
2 | 62053 | 0.027 |
4 | 733186 | 0.026 |
7 | 2215000 | 0.025 |
Price($) | Vol. | No. |
---|---|---|
0.031 | 257351 | 1 |
0.032 | 1625000 | 3 |
0.033 | 1280000 | 2 |
0.034 | 500000 | 1 |
0.035 | 25538 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
WNX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online